OpenBilldrug price receipt

NADAC week of 2026-10-14

GABAPENTIN 600 MG TABLET

For 30 tablets

Pharmacies pay

$1.92 filed

30 × $0.06398 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$3.58 filed

30 × $0.1192 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.9× estimated

Medicare paid 1.9× what pharmacies pay.

Part D averages every strength and form sold under “Gabapentin” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$7.21 estimated

$1.92 + $0.29 (15%) + $5.00 fee per fill = $7.21

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

GABAPENTIN 600 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as gabapentin.

FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.

FDA lists 20 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Rising Pharma Holdings, Inc. and NorthStar Rx LLC.

FDA’s Established Pharmacologic Class for it is Anti-epileptic Agent.

The NADAC file of 2026-10-14 prices it under 51 NDCs (National Drug Codes); the FDA directory lists 39 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.92 for 30 tablets (30 × $0.06398 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 20 labelers

LabelerNDCsPharmacies pay per unit
Exelan Pharmaceuticals Inc.5$0.06398 per EA filed
Precision Dose, Inc.3$0.06398 per EA filed
Advagen Pharma Ltd2$0.06398 per EA filed
Ascend Laboratories, LLC2$0.06398 per EA filed
Aurobindo Pharma Limited2$0.06398 per EA filed
BluePoint Laboratories2$0.06398 per EA filed
Camber Pharmaceuticals, Inc.2$0.06398 per EA filed
Glenmark Pharmaceuticals Inc., USA2$0.06398 per EA filed
Granules Pharmaceuticals Inc.2$0.06398 per EA filed
Mullan Pharmaceutical Inc.2$0.06398 per EA filed
NorthStar Rx LLC2$0.06398 per EA filed
Rising Pharma Holdings, Inc.2$0.06398 per EA filed
ScieGen Pharmaceuticals, Inc.2$0.06398 per EA filed
Strides Pharma Science Limited2$0.06398 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.06398 per EA filed
American Health Packaging1$0.06398 per EA filed
AvPAK1$0.06398 per EA filed
Major Pharmaceuticals1$0.06398 per EA filed
QUALLENT PHARMACEUTICALS HEALTH LLC1$0.06398 per EA filed
Westminster Pharmaceuticals, LLC1$0.06398 per EA filed
Not listed as a package in the FDA directory12$0.06398 per EA filed
All 51 NDCs, with labeler and price
  • 00904-6823-61 · Major Pharmaceuticals · $0.06398 per EA · eff. 2026-09-23 filed
  • 16571-0116-01 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 16571-0116-50 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 16571-0226-01 · Rising Pharma Holdings, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 16571-0226-50 · Rising Pharma Holdings, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 16714-0330-01 · NorthStar Rx LLC · $0.06398 per EA · eff. 2026-09-23 filed
  • 16714-0330-02 · NorthStar Rx LLC · $0.06398 per EA · eff. 2026-09-23 filed
  • 31722-0166-01 · Camber Pharmaceuticals, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 31722-0166-05 · Camber Pharmaceuticals, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 43547-0332-10 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 43547-0332-50 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 43547-0389-10 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 43547-0389-50 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 50228-0177-01 · ScieGen Pharmaceuticals, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 50228-0177-05 · ScieGen Pharmaceuticals, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 50268-0325-11 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 50268-0325-15 · AvPAK · $0.06398 per EA · eff. 2026-09-23 filed
  • 60687-0507-01 · American Health Packaging · $0.06398 per EA · eff. 2026-09-23 filed
  • 60687-0507-11 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 64380-0727-01 · Strides Pharma Science Limited · $0.06398 per EA · eff. 2026-09-23 filed
  • 64380-0727-02 · Strides Pharma Science Limited · $0.06398 per EA · eff. 2026-09-23 filed
  • 65862-0523-01 · Aurobindo Pharma Limited · $0.06398 per EA · eff. 2026-09-23 filed
  • 65862-0523-05 · Aurobindo Pharma Limited · $0.06398 per EA · eff. 2026-09-23 filed
  • 67877-0428-01 · Ascend Laboratories, LLC · $0.06398 per EA · eff. 2026-09-23 filed
  • 67877-0428-05 · Ascend Laboratories, LLC · $0.06398 per EA · eff. 2026-09-23 filed
  • 68001-0411-00 · BluePoint Laboratories · $0.06398 per EA · eff. 2026-09-23 filed
  • 68001-0411-03 · BluePoint Laboratories · $0.06398 per EA · eff. 2026-09-23 filed
  • 68094-0069-59 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 68094-0069-61 · Precision Dose, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 68094-0589-50 · Precision Dose, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 68094-0589-60 · Precision Dose, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 68382-0204-01 · Zydus Pharmaceuticals USA Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 68382-0204-05 · Zydus Pharmaceuticals USA Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 68462-0126-01 · Glenmark Pharmaceuticals Inc., USA · $0.06398 per EA · eff. 2026-09-23 filed
  • 68462-0126-05 · Glenmark Pharmaceuticals Inc., USA · $0.06398 per EA · eff. 2026-09-23 filed
  • 69367-0134-06 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 69367-0346-05 · Westminster Pharmaceuticals, LLC · $0.06398 per EA · eff. 2026-09-23 filed
  • 70010-0227-01 · Granules Pharmaceuticals Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 70010-0227-05 · Granules Pharmaceuticals Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 71093-0111-04 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 71093-0111-05 · not listed as a package in the FDA directory · $0.06398 per EA · eff. 2026-09-23 filed
  • 72888-0131-01 · Advagen Pharma Ltd · $0.06398 per EA · eff. 2026-09-23 filed
  • 72888-0131-05 · Advagen Pharma Ltd · $0.06398 per EA · eff. 2026-09-23 filed
  • 76282-0405-01 · Exelan Pharmaceuticals Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 76282-0405-05 · Exelan Pharmaceuticals Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 76282-0405-90 · Exelan Pharmaceuticals Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 76282-0706-05 · Exelan Pharmaceuticals, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 76282-0706-90 · Exelan Pharmaceuticals, Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 82009-0071-05 · QUALLENT PHARMACEUTICALS HEALTH LLC · $0.06398 per EA · eff. 2026-09-23 filed
  • 83301-0001-01 · Mullan Pharmaceutical Inc. · $0.06398 per EA · eff. 2026-09-23 filed
  • 83301-0001-02 · Mullan Pharmaceutical Inc. · $0.06398 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

20 other products in the NADAC file share the FDA nonproprietary name gabapentin with GABAPENTIN 600 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
GABAPENTIN 100 MG CAPSULE
generic · capsule
$0.02184 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 250 MG/5 ML SOLN
generic · solution / suspension
$0.08761 to $0.1712 per ML filed
eff. 2026-02-18 to 2026-09-23
We don’t know yet
GABAPENTIN 300 MG CAPSULE
generic · capsule
$0.03142 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 400 MG CAPSULE
generic · capsule
$0.04222 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 600 MG TABLET this page
generic · tablet, film coated / tablet / tablet, coated
$0.06398 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 800 MG TABLET
generic · tablet, film coated / tablet / tablet, coated
$0.08829 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN ER 300 MG TABLET
generic · tablet, film coated / tablet
$0.63846 per EA filed
eff. 2026-09-23
$5.0138 per EA filed
Part D 2024 average
GABAPENTIN ER 600 MG TABLET
generic · tablet, film coated / tablet
$1.02497 per EA filed
eff. 2026-09-23
$5.0138 per EA filed
Part D 2024 average
GABARONE 100 MG TABLET
brand · tablet
$8.78889 per EA filed
eff. 2026-09-23
We don’t know yet
GABARONE 400 MG TABLET
brand · tablet
$8.57111 per EA filed
eff. 2026-09-23
We don’t know yet
GRALISE ER 300 MG TABLET
brand · tablet, film coated
$10.18511 per EA filed
eff. 2026-09-23
We don’t know yet
GRALISE ER 450 MG TABLET
brand · tablet, film coated
$10.14274 per EA filed
eff. 2025-12-17
We don’t know yet
GRALISE ER 600 MG TABLET
brand · tablet, film coated
$10.15306 per EA filed
eff. 2026-09-23
We don’t know yet
GRALISE ER 900 MG TABLET
brand · tablet, film coated
$15.20748 per EA filed
eff. 2026-09-23
We don’t know yet
NEURONTIN 100 MG CAPSULE
brand · capsule
$2.95761 per EA filed
eff. 2026-01-01
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 300 MG CAPSULE
brand · capsule
$7.37105 per EA filed
eff. 2026-09-23
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 400 MG CAPSULE
brand · capsule
$8.86718 per EA filed
eff. 2026-01-01
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 600 MG TABLET
brand · tablet, film coated
$14.11861 per EA filed
eff. 2026-09-23
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 800 MG TABLET
brand · tablet, film coated
$16.88137 per EA filed
eff. 2026-09-23
$8.87549 per EA filed
Part D 2024 average
RELGAABI 300 MG CAPSULE
generic · capsule
$0.03142 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
RELGAABI 400 MG CAPSULE
generic · capsule
$0.04222 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 51 NDCs’ NADAC prices is $0.06398 per EA filed.

Of the 85 other products in FDA’s Anti-epileptic Agent class priced per EA, 80 have a higher middle NADAC price and 5 a lower one. The one in the middle is PHENYTEK 200 MG CAPSULE, at $1.4026 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $3.58 for 30 tablets, at an average of $0.1192 per EA in 2024 (2024-01-01 to 2024-12-31) for “Gabapentin”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 36,804,628 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for GABAPENTIN 600 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Gabapentin / Gabapentin: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. 254 of 262 NADAC NDCs joined to this name are priced per EA (8 per ML): CMS's average mixes those units.